| | Major laboratory methodologies | Correspondence with | Biomarkers | References |
| Nucleic acids | RT-PCR | Overall survival | miRNA-29c | [11] | RT-PCR | Breslow index | miRNA-221 | [11] | Metabolites | HPLC | Breslow index | 6H5MI2C | [11] | HPLC | Poor prognosis, response to treatment | 5-S-cysteinyl-DOPA | [11] | HPLC | Tumor burden, tumor progression | l-DOPA/l-tyrosine | [11] | Progenitor/stem cell-like markers | IHC | Disease | SOX protein family | [14, 15] | S100 proteins | ELISA, LIA | Tumor stage, survival, recurrence | S100B | [16, 17] | MS, IHC | Tumor progression | S100A13 | [18, 19] | Northern blot | Tumor progression (negative correlation) | S100A2 | [11] | IHC | Tumor progression | S100P | [11, 20] | IHC, ELISA, FC | Tumor progression | S100A8/A9 | [21, 22] | IHC | Tumor progression | S100A4 | [11] | Northern blot | Survival | S100A6 | [11] | Secreted proteins/antigens | ELISA | Tumor stage, tumor progression, poor prognosis | YKL-40 | [11] | ELISA | Survival, recurrence | TA90 | [11] | ELISA, RT-PCR | Tumor stage, survival, tumor progression | VEGF | [11] | ELISA | Survival poor prognosis | MIA | [11 | RT-PCR | Tumor progression | MAGE | [11] | ELISA | Tumor burden | VEGF-C, VEGFR-3 | [11] | RT-PCR | Tumor stage | MART-1 | [11] | IP | Survival tumor progression | C-reactive protein | [11] | IHC, TMA | Breslow index, survival, poor prognosis | Osteopontin | [11] | ELISA | Tumor progression | CYT-MAA | [11] | ELISA | Survival | sICAM, sVCAM | [11] | IHC, ELISA | Poor prognosis, tumor progression | Galectin-3 | [11] | IHC, ELISA | Tumor stage, tumor progression, overall survival | CEACAM | [11] | Enzymes | HPLC | Overall survival | IDO | [23] | RT-PCR, nested RT-PCR | Poor prognosis, survival rate, overall survival | Tyrosinase | [11] | IHC | Disease-free survival | MMP-1, MMP-3 | [11] | Cytomorphology, IHC | Overall survival | CD10 | [24, 25] | IHC | Disease | Cathepsin K | [26] | ELISA | Disease, poor prognosis | MMP-9 | [11, 27] | ELISA | Disease-free and overall survival | TIMP-1 | [27] | IHC | Breslow index, tumor progression | Cox-2 | [11] | IHC | Overall survival | MMP-12 | [28] | Photometric assay, meta-analysis# | Prognosis, tumor stage, survival rate | LDH | [11] | IHC | Tumor progression | MT1-MMP | [29] | IHC | Overall survival | Legumain | [30] | TMA, IHC | Tumor progression | MMP-2 | [31, 32] | IHC | Progression-free survival | MMP-23 | [33] |
|
|